Skip to main content

Advertisement

Log in

In Vitro and In Vivo Evaluation of Hydroxyzine Hydrochloride Microsponges for Topical Delivery

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Hydroxyzine HCl is used in oral formulations for the treatment of urticaria and atopic dermatitis. Dizziness, blurred vision, and anticholinergic responses, represent the most common side effects. It has been shown that controlled release of the drug from a delivery system to the skin could reduce the side effects while reducing percutaneous absorption. Therefore, the aim of the present study was to produce an effective drug-loaded dosage form that is able to control the release of hydroxyzine hydrochloride into the skin. The Microsponge Delivery System is a unique technology for the controlled release of topical agents, and it consists of porous polymeric microspheres, typically 10–50 μm in diameter, loaded with active agents. Eudragit RS-100 microsponges of the drug were prepared by the oil in an oil emulsion solvent diffusion method using acetone as dispersing solvent and liquid paraffin as the continuous medium. Magnesium stearate was added to the dispersed phase to prevent flocculation of Eudragit RS-100 microsponges. Pore inducers such as sucrose and pregelatinized starch were used to enhance the rate of drug release. Microsponges of nearly 98% encapsulation efficiency and 60–70% porosity were produced. The pharmacodynamic effect of the chosen preparation was tested on the shaved back of histamine-sensitized rabbits. Histopathological studies were driven for the detection of the healing of inflamed tissues.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13

Similar content being viewed by others

REFERENCES

  1. Villamizar L, Barrera G, Marina CA, Martínez F. Eudragit S100 microparticles containing Spodoptera frugiperda nucleopolyehedrovirus: physicochemical characterization, photostability and in vitro virus release. J Microencapsulation. 2010;27(4):314–24.

    Article  PubMed  CAS  Google Scholar 

  2. Mana Z, Pellequer Y, Lamprecht A. Oil-in-oil microencapsulation technique with an external perfluorohexane phase. Int J Pharm. 2007;338:231–7.

    Article  PubMed  CAS  Google Scholar 

  3. Viswanathan NB, Thomas PA, Pandit JK, Kulkarni MG, Mashelkar RA. Preparation of non-porous microspheres with high entrapment efficiency of proteins by a (water-in-oil)-in-oil emulsion technique. J Contr Rel. 1999;58:9–20.

    Article  CAS  Google Scholar 

  4. Bogataj M, Mrhar A, Kristl A, Kozjek F. Eudragit E microspheres containing bacampicillin: preparation by solvent removal methods. J Microencapsulation. 1991;8:401–6.

    Article  PubMed  CAS  Google Scholar 

  5. Benoit JP, Marchais H, Rolland H, Velde VV. Biodegredable microspheres: advances in production technology. In: Benita S, editor. Microencapsulation methods and industrial applications. New York: Marcel Dekker; 1996. p. 35–72.

    Google Scholar 

  6. Thies C. Formation of degradable drug-loaded micro-particles by in-liquid drying processes. In: Donbrow M, editor. Microcapsules and nanoparticles in medicine and pharmacy. London: CRC; 1992. p. 47–71.

    Google Scholar 

  7. Bogataj M, Mrhar A. Determination of microsphere solidification time in the solvent evaporation process. J Microencapsulation. 2005;22(1):81–90.

    Article  PubMed  Google Scholar 

  8. Kibbe AH. Handbook of pharmaceutical excipients. 3rd ed. Washington, DC: American Pharmaceutical Association and Pharmaceutical; 2000. p. 401–6.

    Google Scholar 

  9. Eudragit Data Sheets, Industrial Products Division, Röhm Pharma GmbH, Weiterstadt, Germany.

  10. US Pharmacopeia 24, US Pharmacopeial Convention, Rockville, MD, 2000, pp. 2477–2478 and 1945–1946.

  11. Haznedar S, Dortunç B. Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide. Int J Pharm. 2004;269:131–40.

    Article  PubMed  CAS  Google Scholar 

  12. Kiliçarslan M, Baykara T. The effect of the drug/polymer ratio on the properties of the verapamil HCl loaded microspheres. Int J Pharm. 2003;252:99–109.

    Article  PubMed  Google Scholar 

  13. Kim CK, Kim MJ, Oh KH. Preparation and evaluation of sustained release microspheres of terbutaline sulfate. Int J Pharm. 1994;106:213–9.

    Article  CAS  Google Scholar 

  14. Goto S, Kawata M, Nakamura M, Maekawa K, Aoyama T. Eudragit E, L and S (acrylic resins) microcapsules as pH sensitive release preparations of ketoprofen. J Microencapsulation. 1986;3(b):305–16.

    Article  PubMed  CAS  Google Scholar 

  15. Kawata M, Nakamura M, Goto S, Aoyama T. Preparation and dissolution pattern of Eudragit RS microcapsules containing ketoprofen. Chem Pharm Bull. 1986;34:2618–23.

    PubMed  CAS  Google Scholar 

  16. Yüksel N, Baykara T. Preparation of polymeric microspheres by the solvent evaporation method using sucrose stearate as droplet stabilizer. J Microencapsulation. 1997;14:725–33.

    Article  PubMed  Google Scholar 

  17. Bhardwaj SB, Shukla AJ, Collins CC. Effect of varying drug loading on particle size distribution and drug release kinetics of verapamil hydrochloride microspheres prepared with cellulose esters. J Microencapsulation. 1995;12:71–81.

    Article  PubMed  CAS  Google Scholar 

  18. El Gibaly, Abdel-Ghaffar SK. Effect of hexacosanol on the characteristics of novel sustained release allopurinol solid lipospheres (SLS): factorial design application and product evaluation. Int J Pharm. 2005;294:33–51.

    Article  PubMed  Google Scholar 

  19. Toongsuwan S, Li L, Erickson BK, Chang H. Formulation and characterization of bupivacaine lipospheres. Int J Pharm. 2004;280:57–65.

    Article  PubMed  CAS  Google Scholar 

  20. Iannuccelli V, Sala N, Tursilli R. Influence of liposphere preparation on butyl-methoxydibenzoyl methane photostability. Eur J Pharm Biopharm. 2006;63:140–5.

    Article  PubMed  CAS  Google Scholar 

  21. Tursilli R, Casolari A, Iannuccelli V, Scalia S. Enhancement of melatonin photostability by encapsulation in lipospheres. J Pharm Biomed Anal. 2006;40:910–4.

    Article  PubMed  CAS  Google Scholar 

  22. Nasr M, Mansour S, Mortada N, El Shamy AA. Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation. AAPS PharmSciTech. 2008;9(1):154–62.

    Article  PubMed  CAS  Google Scholar 

  23. Pauli G, Frossard N. Étude des antihistaminiques par la technique du « wheal and flare »:quelle signification faut-il lui accorder ? Revue française d’allergologie et d’immunologie Clinique. 2004;44:194–8.

    Google Scholar 

  24. El zainy A, Simons KJ. Hydroxyzine from topical phospholipid liposomal formulations: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model. AAPS PharmSci. 2003;5(4), Article 28.

    Google Scholar 

  25. Simons FER, Silver NA, Gu X, Simons KJ. Skin concentrations of H1-receptor antagonists. J Allergy Clin Immunol. 2001;107:526–30.

    Article  PubMed  CAS  Google Scholar 

  26. Banchroft JD, Stevens A, Turner DR. Theory and practice of histological techniques. 4th ed. New York: Churchil Livingstone; 1996. p. 445–55.

    Google Scholar 

  27. Pongpaibul Y, Price JC, Whitworth CW. Preparation and evaluation of controlled release indomethacin microspheres. Drug Dev Ind Pharm. 1984;10:1597–616.

    Article  CAS  Google Scholar 

  28. Malamataris S, Avgerinos A. Controlled release indomethacin microspheres prepared by using an emulsion solvent-diffusion technique. Int J Pharm. 1990;62:105–11.

    Article  CAS  Google Scholar 

  29. Chiao CSL, Price JC. Formulation, preparation and dissolution characteristics of propranolol hydrochloride microspheres. J Microencapsulation. 1994;11:153–9.

    Article  PubMed  CAS  Google Scholar 

  30. Goto S, Kawata M, Nakamura M, Aoyama T. Effect of magnesium stearate in the preparation of Eudragit RS microcapsules containing drugs. Yakugaku Zasshi. 1985;105:1087–95.

    PubMed  CAS  Google Scholar 

  31. Goto S, Kawata M, Nakamura M, Maekawa K, Aoyama T. Eudragit RS and RL (acrylic resins) microcapsules as pH insensitive and sustained release preparations of ketoprofen. J Microencapsulation. 1986;3(4):293–304.

    Article  PubMed  CAS  Google Scholar 

  32. Arshady R. Preparation of biodegradable microspheres and microcapsules 2. Polylactides and related polyesters. J Contr Rel. 1991;17:1–22.

    Article  CAS  Google Scholar 

  33. Horoz BB, Kiliçarslan M, Yüksel N, Baykara T. Influence of aluminum tristearate and sucrose stearate as the dispersing agents on physical properties and release characteristics of Eudragit RS microspheres. AAPS PharmSciTech. 2006;7(1):E111–7.

    Article  Google Scholar 

  34. Song M, Li N, Sun S, Tiedt LR. Effect of viscosity and concentration of wall former, emulsifier and pore-inducer on the properties of amoxicillin microcapsules prepared by emulsion solvent evaporation. П Farmaco. 2005;60:261–7.

    Article  CAS  Google Scholar 

  35. Singer SJ, Nicolson GL. The fluid mosaic model of the structure of cell membranes. Science. 1972;175(23):720–31.

    Article  PubMed  CAS  Google Scholar 

  36. Santoyo S, Ga de Jalón E, Ygartua P, Renedo MJ, Blanco-Príeto MJ. Optimization of topical cidofovir penetration using microparticles. Int J Pharm. 2002;242(1–2):107–13.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christianne Mounir Zaki Rizkalla.

Additional information

The protocol of the present work was approved by the Experiments and Advanced Pharmaceutical Research Unit (EAPRU), Faculty of Pharmacy, Cairo University, Cairo, Egypt.

Any experiments involving the use of animals were conducted in accordance with the principles of Laboratory Animal Care and were approved by the institutional ethics committee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zaki Rizkalla, C.M., latif Aziz, R. & Soliman, I.I. In Vitro and In Vivo Evaluation of Hydroxyzine Hydrochloride Microsponges for Topical Delivery. AAPS PharmSciTech 12, 989–1001 (2011). https://doi.org/10.1208/s12249-011-9663-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-011-9663-5

KEYWORDS

Navigation